Literature DB >> 9625335

Diagnosis of the first Japanese patient with 3-oxo-delta4-steroid 5beta-reductase deficiency by use of immunoblot analysis.

A Kimura1, K H Kondo, K I Okuda, S Higashi, M Suzuki, T Kurosawa, M Tohma, T Inoue, A Nishiyori, M Yoshino, H Kato, T Setoguchi.   

Abstract

UNLABELLED: A 3-oxo-delta4-steroid 5beta-reductase (5beta-reductase) deficiency is difficult to diagnose because severe liver damage can result in a similar pattern of metabolite excretion. We investigated the usefulness of immunoblot analysis for diagnosis of 5beta-reductase deficiency and quantitatively analysed urinary bile acids by gas chromatography-mass spectrometry in a 5-month-old Japanese boy with severe neonatal cholestasis associated with hypertyrosinaemia. A liver sample was examined by immunoblot analysis using monoclonal antibodies against 5beta-reductase. Urinary 3-oxo-delta4 bile acids accounted for 88.3% of total bile acids, 5alpha-bile acids for 0.9%, and primary bile acids for 9.1%. Immunoblot analysis of the liver tissue showed an indistinct band of 5beta-reductase.
CONCLUSIONS: These findings suggest that this patient had a secondary 5beta-reductase deficiency due to severe liver damage, even though 3-oxo-delta4 bile acids constituted more than 70% of total urinary bile acids. However, the patient may possibly have had an inherited 5beta-reductase deficiency.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9625335     DOI: 10.1007/s004310050835

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  19 in total

1.  Determination of 3-oxo-delta4- and 3-oxo-delta4,6-bile acids and related compounds in biological fluids of infants with cholestasis by gas chromatography-mass spectrometry.

Authors:  M Suzuki; T Murai; T Yoshimura; A Kimura; T Kurosawa; M Tohma
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1997-05-23

2.  3-Oxo-delta 4 bile acids in liver disease.

Authors:  P T Clayton; E Patel; A M Lawson; R A Carruthers; M S Tanner; B Strandvik; B Egestad; J Sjövall
Journal:  Lancet       Date:  1988-06-04       Impact factor: 79.321

3.  Delta 4-3-oxosteroid 5 beta-reductase deficiency and neonatal hemochromatosis.

Authors:  P T Clayton
Journal:  J Pediatr       Date:  1994-11       Impact factor: 4.406

4.  Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis.

Authors:  J J Cali; C L Hsieh; U Francke; D W Russell
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

5.  Delta 4-3-oxosteroid 5 beta-reductase deficiency causing neonatal liver failure and hemochromatosis.

Authors:  B L Shneider; K D Setchell; P F Whitington; K A Neilson; F J Suchy
Journal:  J Pediatr       Date:  1994-02       Impact factor: 4.406

6.  delta 4-3-Oxosteroid 5 beta-reductase. Structure and function.

Authors:  Y Onishi; M Noshiro; T Shimosato; K Okuda
Journal:  Biol Chem Hoppe Seyler       Date:  1991-12

7.  Improved synthesis of 3-keto, 4-ene-3-keto, and 4,6-diene-3-keto bile acids.

Authors:  R A Leppik
Journal:  Steroids       Date:  1983-04       Impact factor: 2.668

8.  Profile of urinary bile acids in familial intrahepatic cholestasis with Coombs' negative haemolytic anaemia.

Authors:  A Kimura; K Ushijima; M Suzuki; M Tohma; T Inokuchi; H Kato
Journal:  Acta Paediatr       Date:  1995-10       Impact factor: 2.299

9.  Synthesis of 6-hydroxylated bile acids and identification of 3 alpha,6 alpha,7 alpha,12 alpha-tetrahydroxy-5 beta-cholan-24-oic acid in human meconium and neonatal urine.

Authors:  T Kurosawa; R Mahara; H Nittono; M Tohma
Journal:  Chem Pharm Bull (Tokyo)       Date:  1989-02       Impact factor: 1.645

10.  Bile acid metabolism in early life: studies of amniotic fluid.

Authors:  M Nakagawa; K D Setchell
Journal:  J Lipid Res       Date:  1990-06       Impact factor: 5.922

View more
  5 in total

1.  Characterization of disease-related 5beta-reductase (AKR1D1) mutations reveals their potential to cause bile acid deficiency.

Authors:  Jason E Drury; Rebekka Mindnich; Trevor M Penning
Journal:  J Biol Chem       Date:  2010-06-03       Impact factor: 5.157

2.  Crystal structure of human liver Delta4-3-ketosteroid 5beta-reductase (AKR1D1) and implications for substrate binding and catalysis.

Authors:  Luigi Di Costanzo; Jason E Drury; Trevor M Penning; David W Christianson
Journal:  J Biol Chem       Date:  2008-04-11       Impact factor: 5.157

3.  In-Depth Dissection of the P133R Mutation in Steroid 5β-Reductase (AKR1D1): A Molecular Basis of Bile Acid Deficiency.

Authors:  Mo Chen; Yi Jin; Trevor M Penning
Journal:  Biochemistry       Date:  2015-10-06       Impact factor: 3.162

Review 4.  Human aldo-keto reductases: Function, gene regulation, and single nucleotide polymorphisms.

Authors:  Trevor M Penning; Jason E Drury
Journal:  Arch Biochem Biophys       Date:  2007-05-11       Impact factor: 4.013

5.  Liver and the defects of cholesterol and bile acids biosynthesis: Rare disorders many diagnostic pitfalls.

Authors:  Gaetano Corso; Antonio Dello Russo; Monica Gelzo
Journal:  World J Gastroenterol       Date:  2017-08-07       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.